Interim Report January – September 2021
STOCKHOLM, SE / ACCESSWIRE / November 23, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)July to SeptemberNet sales amounted to MSEK 0...
STOCKHOLM, SE / ACCESSWIRE / November 23, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)July to SeptemberNet sales amounted to MSEK 0...
FDA feedback provides clear clinical path for NEO-001, the first obesity drug therapy focused on neuropharmacological and behavioral changes for...
Toronto, Ontario--(Newsfile Corp. - November 23, 2021) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
LONDON--(BUSINESS WIRE)--#cardiovascular--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced that Damien McDonald, Chief Executive Officer, will...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the Piper Sandler 33rd Annual...
Trenkle brings extensive federal experience to Onyx’s industry leading health data interoperability platform ELKRIDGE, Md.--(BUSINESS WIRE)--#healthcare--Onyx Technology, LLC, a NewWave...
Leader in women's health to showcase clinically proven solutions across the continuum of breast and skeletal health at annual meeting...
The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS...
Vancouver, British Columbia--(Newsfile Corp. - November 23, 2021) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence"...